================================================================================
AADB DATA ACCESS - MONTHLY REPORT FOR NIH
Reporting Period: November 2025
================================================================================

KEY PERFORMANCE INDICATORS
--------------------------------------------------------------------------------

Metric                         Current                   Target                    Status    
--------------------------------------------------------------------------------
Average Total Process Time     165 days                  100 days                  ✗         
IRB Process Time               120 days (12% on target)  ≤60 days (80% target)     ✗         
DUA Process Time               155 days (7% on target)   ≤90 days (80% target)     ✗         


PROGRESS UPDATES
--------------------------------------------------------------------------------

• Projects Completed: 14
• Total Active Projects: 17
• High-Risk Projects Requiring Intervention: 9


CHALLENGES AND MITIGATION STRATEGIES
--------------------------------------------------------------------------------

1. CRITICAL: IRB compliance at 11.8% (Target: 80%)
2. CRITICAL: DUA compliance at 5.9% (Target: 80%)
3. WARNING: 4 projects (23.5%) exceeding 180 days
4. BOTTLENECK: NOA to Initial Consult at 2.5x benchmark
5. BOTTLENECK: Intake to Request Submission at 1.6x benchmark
6. BOTTLENECK: Submission to Finalization at 2.0x benchmark
7. BOTTLENECK: IRB Process at 2.0x benchmark
8. BOTTLENECK: DUA Process at 1.7x benchmark
9. BOTTLENECK: Total Process (NOA to Access) at 1.6x benchmark


ACTION ITEMS FOR NEXT PERIOD
--------------------------------------------------------------------------------

1. Accelerate initial consultation scheduling: Currently 74 days avg (target: 30 days). Increase staff capacity.
2. Address Submission to Finalization delays: Reduce from 61 to 30 days through process optimization.
3. Streamline IRB process: Currently 120 days avg (target: 60 days). Consider expedited review procedures.
4. Focus improvement efforts on CDP: Only 0% meeting all targets. Conduct detailed process review.
5. Focus improvement efforts on CLINAQ Cohort 1: Only 0% meeting all targets. Conduct detailed process review.

================================================================================